CEO Jeff Wolf discusses the powerful immunostimulatory technology underlying Heat's cell-based #cancer therapeutics and #COVID-19 #vaccine candidate in the Q2 issue of Pharma's Almanac: https://t.co/JQfTsbLUP2
— NightHawk Biosciences (@NightHawk_Bio) July 14, 2020
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.